Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma

Haematologica. 2025 Mar 1;110(3):764-767. doi: 10.3324/haematol.2024.285933.
No abstract available